跳至主要内容
临床试验/NCT04862689
NCT04862689已完成不适用

A Prospective, Multicenter, Single-arm Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA Study)

Vascular Solutions LLC14 个研究点 分布在 2 个国家目标入组 60 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
14
主要终点
Effectiveness of device success in dilatation/pre-dilatation of coronary stenosis during PCI.

研究概览

简要总结

The objective of this study is to demonstrate safe and effective use of the Ringer perfusion balloon catheter for dilatation/pre-dilatation of coronary stenoses during percutaneous coronary intervention (PCI).

详细描述

A prospective, multicenter, single-arm clinical study. The study will be conducted in 3 to 5 investigational sites in the US and Canada and will enroll up to 60 participants. The population for this study is adult participants undergoing non-emergent percutaneous coronary intervention (PCI) as a stand-alone procedure or following non-emergent diagnostic angiography performed during the same procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Female subjects >18 years old.
  • Patients undergoing clinically indicated non-emergent PCI as a stand-alone procedure or in combination with diagnostic angiography during the same procedure.
  • Study target lesion characteristics: a) native de-novo coronary stenosis of at least 70% visually estimated stenosis, or at least 50% visually estimated stenosis and shown to be physiologically significant by flow-mediated criteria (FFR <0.80, IFR <0.91); b) estimated reference vessel diameter 2.0-4.5mm; c) lesion length <25mm; d) calcification not greater than mild.
  • Per investigator assessment, the patient may benefit from inflation distal perfusion during balloon inflation. Examples include, but are not limited to: (i) LV systolic dysfunction with LVEF<50% by any modality; (ii) a territory subtended by the target vessel downstream from the target lesion that is estimated to be in excess of 25% of viable LV mass; (iii) prior hemodynamic or electrical instablility during intervention on the target lesion; (iv) the potential to avoid placement of a coronary stent if a stent-like result can be achieved through prolonged balloon inflation.
  • Female subjects of childbearing potential must have a negative pregnancy test per standard of care for PCI and be practicing contraception.
  • Informed consent provided.

排除标准

  • Hemodynamic or arrhythmic instability within 48 hours or a myocardial infarction within 72 hours of PCI.
  • More than 2 lesions planned during index PCI.
  • Procedural complication developing prior to PCI of study target.
  • Ejection fraction (EF) <25%.
  • Creatinine clearance (Cr-Cl) <25 mg/dL.
  • Baseline flow at study target <TIMI-2.

结局指标

主要结局

Effectiveness of device success in dilatation/pre-dilatation of coronary stenosis during PCI.

时间窗: During Procedure

Successful delivery, inflation, deflation and withdrawal of the Ringer device; final thrombolysis in myocardial infarction (TIMI) flow grade of 3 at the conclusion of the PCI procedure.

Rate of clinically relevant events

时间窗: Discharge or 30 days, whichever comes first

Rate of Ringer related complications arising during delivery, inflation or removal of Ringer; freedom from major cardiac adverse events (MACE)

次要结局

  • TIMI Flow(During Procedure)
  • Successful PCI(During Procedure)
  • Ringer Inflation(During Procedure)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验